Voyageur Pharmaceuticals (TSXV:VM) FCF Margin % : 0.00% (As of May. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Voyageur Pharmaceuticals's Free Cash Flow for the three months ended in May. 2024 was C$-0.19 Mil. Voyageur Pharmaceuticals's Revenue for the three months ended in May. 2024 was C$0.00 Mil. Therefore, Voyageur Pharmaceuticals's FCF Margin % for the quarter that ended in May. 2024 was 0.00%.

As of today, Voyageur Pharmaceuticals's current FCF Yield % is -5.86%.

The historical rank and industry rank for Voyageur Pharmaceuticals's FCF Margin % or its related term are showing as below:

TSXV:VM's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.055
* Ranked among companies with meaningful FCF Margin % only.

Voyageur Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Voyageur Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals FCF Margin % Chart

Voyageur Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

FCF Margin %

Get a 7-Day Free Trial

Voyageur Pharmaceuticals Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Voyageur Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Voyageur Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's FCF Margin % falls into.

Voyageur Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Voyageur Pharmaceuticals's FCF Margin for the fiscal year that ended in Nov. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Nov. 2023 )	/	Revenue (A: Nov. 2023 )
	=	-0.991	/	0
	=	%

Voyageur Pharmaceuticals's FCF Margin for the quarter that ended in May. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: May. 2024 )	/	Revenue (Q: May. 2024 )
	=	-0.189	/	0
	=	%

Voyageur Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

VYYRF:USA

Address

333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1

Website

https://www.voyageurpharmaceuticals.ca

Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.

Executives

Charles Littlejohn

10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines